Literature DB >> 9596734

Molecular and immunological analyses of the Mycobacterium avium homolog of the immunodominant Mycobacterium leprae 35-kilodalton protein.

J A Triccas1, N Winter, P W Roche, A Gilpin, K E Kendrick, W J Britton.   

Abstract

The analysis of host immunity to mycobacteria and the development of discriminatory diagnostic reagents relies on the characterization of conserved and species-specific mycobacterial antigens. In this report, we have characterized the Mycobacterium avium homolog of the highly immunogenic M. leprae 35-kDa protein. The genes encoding these two proteins were well conserved, having 82% DNA identity and 90% identity at the amino acid level. Moreover both proteins, purified from the fast-growing host M. smegmatis, formed multimeric complexes of around 1000 kDa in size and were antigenically related as assessed through their recognition by antibodies and T cells from M. leprae-infected individuals. The 35-kDa protein exhibited significant sequence identity with proteins from Streptomyces griseus and the cyanobacterium Synechoccocus sp. strain PCC 7942 that are up-regulated under conditions of nutrient deprivation. The 67% amino acid identity between the M. avium 35-kDa protein and SrpI of Synechoccocus was spread across the sequences of both proteins, while the homologous regions of the 35-kDa protein and the P3 sporulation protein of S. griseus were interrupted in the P3 protein by a divergent central region. Assessment by PCR demonstrated that the gene encoding the M. avium 35-kDa protein was present in all 30 M. avium clinical isolates tested but absent from M. intracellulare, M. tuberculosis, or M. bovis BCG. Mice infected with M. avium, but not M. bovis BCG, developed specific immunoglobulin G antibodies to the 35-kDa protein, consistent with the observation that tuberculosis patients do not recognize the antigen. Strong delayed-type hypersensitivity was elicited by the protein in guinea pigs sensitized with M. avium.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9596734      PMCID: PMC108256          DOI: 10.1128/IAI.66.6.2684-2690.1998

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  38 in total

Review 1.  Clinical aspects of mycobacterial infections in HIV infection.

Authors:  R J Coker; T J Hellyer; I N Brown; J N Weber
Journal:  Res Microbiol       Date:  1992-05       Impact factor: 3.992

Review 2.  Mycobacterial protein antigens: a compilation.

Authors:  D B Young; S H Kaufmann; P W Hermans; J E Thole
Journal:  Mol Microbiol       Date:  1992-01       Impact factor: 3.501

3.  Evaluation of the clinical usefulness of mycobacterial skin test antigens in adults with pulmonary mycobacterioses.

Authors:  R E Huebner; M F Schein; G M Cauthen; L J Geiter; M J Selin; R C Good; R J O'Brien
Journal:  Am Rev Respir Dis       Date:  1992-05

4.  T-cell responses to fractionated antigens of Mycobacterium w, a candidate anti-leprosy vaccine, in leprosy patients.

Authors:  A Yadava; N R Suresh; S A Zaheer; G P Talwar; R Mukherjee
Journal:  Scand J Immunol       Date:  1991-07       Impact factor: 3.487

5.  Nucleotide sequence analysis and serologic characterization of a 27-kilodalton Mycobacterium intracellulare lipoprotein.

Authors:  J Nair; D A Rouse; S L Morris
Journal:  Infect Immun       Date:  1993-03       Impact factor: 3.441

6.  Skin testing with recombinant Mycobacterium intracellulare antigens.

Authors:  S L Morris; J C Mackall; A Malik; D A Rouse; S D Chaparas
Journal:  Tuber Lung Dis       Date:  1992-06

7.  Survival of patients with acquired immune deficiency syndrome and disseminated Mycobacterium avium complex infection with and without antimycobacterial chemotherapy.

Authors:  C R Horsburgh; J A Havlik; D A Ellis; E Kennedy; S A Fann; R E Dubois; S E Thompson
Journal:  Am Rev Respir Dis       Date:  1991-09

8.  Comparative antigenic analysis of Mycobacterium avium complex (MAC) isolates from AIDS patients.

Authors:  R G Deshpande; M B Khan; G Navalkar
Journal:  Tuber Lung Dis       Date:  1992-12

9.  Nucleotide sequence analysis and serologic characterization of the Mycobacterium intracellulare homologue of the Mycobacterium tuberculosis 19 kDa antigen.

Authors:  J Nair; D A Rouse; S L Morris
Journal:  Mol Microbiol       Date:  1992-06       Impact factor: 3.501

10.  Transcription and expression analysis, using lacZ and phoA gene fusions, of Mycobacterium fortuitum beta-lactamase genes cloned from a natural isolate and a high-level beta-lactamase producer.

Authors:  J Timm; M G Perilli; C Duez; J Trias; G Orefici; L Fattorini; G Amicosante; A Oratore; B Joris; J M Frère
Journal:  Mol Microbiol       Date:  1994-05       Impact factor: 3.501

View more
  15 in total

1.  Comparative protective effects of recombinant DNA and Mycobacterium bovis bacille Calmette-Guérin vaccines against M. avium infection.

Authors:  E Martin; J A Triccas; A T Kamath; N Winter; W J Britton
Journal:  Clin Exp Immunol       Date:  2001-12       Impact factor: 4.330

2.  EshA accentuates ppGpp accumulation and is conditionally required for antibiotic production in Streptomyces coelicolor A3(2).

Authors:  Natsumi Saito; Jun Xu; Takeshi Hosaka; Susumu Okamoto; Hiroyuki Aoki; Mervyn J Bibb; Kozo Ochi
Journal:  J Bacteriol       Date:  2006-07       Impact factor: 3.490

3.  Identification and characterization of a developmentally regulated protein, EshA, required for sporogenic hyphal branches in Streptomyces griseus.

Authors:  J Kwak; L A McCue; K Trczianka; K E Kendrick
Journal:  J Bacteriol       Date:  2001-05       Impact factor: 3.490

4.  Profiling bovine antibody responses to Mycobacterium avium subsp. paratuberculosis infection by using protein arrays.

Authors:  John P Bannantine; Michael L Paustian; W Ray Waters; Judith R Stabel; Mitchell V Palmer; Lingling Li; Vivek Kapur
Journal:  Infect Immun       Date:  2007-11-26       Impact factor: 3.441

5.  Molecular and functional analyses of the gene (eshA) encoding the 52-kilodalton protein of Streptomyces coelicolor A3(2) required for antibiotic production.

Authors:  S Kawamoto; M Watanabe; N Saito; A Hesketh; K Vachalova; K Matsubara; K Ochi
Journal:  J Bacteriol       Date:  2001-10       Impact factor: 3.490

6.  Protection against virulent Mycobacterium avium infection following DNA vaccination with the 35-kilodalton antigen is accompanied by induction of gamma interferon-secreting CD4(+) T cells.

Authors:  E Martin; A T Kamath; J A Triccas; W J Britton
Journal:  Infect Immun       Date:  2000-06       Impact factor: 3.441

7.  Heterologous expression of a gene encoding a 35 kDa protein of Mycobacterium avium paratuberculosis in Escherichia coli.

Authors:  S H Basagoudanavar; P P Goswami; V Tiwari; A K Pandey; N Singh
Journal:  Vet Res Commun       Date:  2004-04       Impact factor: 2.459

8.  Gamma interferon responses induced by a panel of recombinant and purified mycobacterial antigens in healthy, non-mycobacterium bovis BCG-vaccinated Malawian young adults.

Authors:  Gillian F Black; Rosemary E Weir; Steven D Chaguluka; David Warndorff; Amelia C Crampin; Lorren Mwaungulu; Lifted Sichali; Sian Floyd; Lyn Bliss; Elizabeth Jarman; Linda Donovan; Peter Andersen; Warwick Britton; Glyn Hewinson; Kris Huygen; Jens Paulsen; Mahavir Singh; Ross Prestidge; Paul E M Fine; Hazel M Dockrell
Journal:  Clin Diagn Lab Immunol       Date:  2003-07

9.  The combination of plasmid interleukin-12 with a single DNA vaccine is more effective than Mycobacterium bovis (bacille Calmette-Guèrin) in protecting against systemic Mycobacterim avium infection.

Authors:  Ela Martin; Arun T Kamath; Helen Briscoe; Warwick J Britton
Journal:  Immunology       Date:  2003-06       Impact factor: 7.397

Review 10.  Production of recombinant proteins in Mycobacterium smegmatis for structural and functional studies.

Authors:  Ghader Bashiri; Edward N Baker
Journal:  Protein Sci       Date:  2014-11-13       Impact factor: 6.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.